PATENT CLAIM ANALYSIS

Application Number: 16181098
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-02
Patent Classification: ["424", "130100"]

Abstract:
The present invention related to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. Specifically, the invention provides a method of identifying tumor specific neoantigens that alone or in combination with other tumor-associated peptides serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumor responses.

Claim (Index 2):
The method of  claim 1 , further comprising\n (a) producing at least two cancer neoantigen peptides comprising the at least two epitopes selected in (c), wherein producing the at least two cancer neoantigen peptides comprises expressing or synthesizing the at least two cancer neoantigen peptides; or (b) producing one or more polynucleotides encoding the at least two cancer neoantigen peptides.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 98.0
- Lexical Diversity: 1.22727
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13108610', '15154543', '15466729', '14850864', '11942607']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7264612581120559
- 35 USC 102 Novelty (BERT): 0.6008697308556853
- Combined Prediction Score: 0.7139021053864189
- Mean Citation Score: 379.90037
- Max Citation Score: 598.5436
- Similarity Product: 455.0316244410037

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test